Focus: Gentell is a wound care biotechnology company founded in 1994, headquartered in Yardley, PA, with a focus on ophthalmology applications within the wound care space. The company operates as a specialized biotech player in a mature, niche therapeutic segment.
Profile data last refreshed 10h ago · AI intelligence enriched 1w ago
Stable — net -4 jobs in 30d
6 added, 10 removed. Backfill posture.
Best suited for candidates seeking stable employment in a niche specialty with operational/commercial emphasis rather than pipeline-driven discovery innovation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Gentell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Gentell's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles